netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.06  Expand sub section  Drugs used in nausea and vertigo
04.06  Expand sub section  Antihistamines
04.06  Expand sub section  Phenothiazines and related drugs
04.06  Expand sub section  Domperidone and metoclopramide
04.06  Expand sub section  5HT3 antagonists to top
Granisetron
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
 
   
Ondansetron
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary

Amber Amber for licensed indications of post operative nausea and vomiting ,and nausea and vomiting related to chemotherapy.

AmberAmber for the unlicensed indications of pallitative care where recommended by the pallitative care team.

Red Traffic Light  For all other indications

Tablets are the preferred formulation.

If patient has swallowing difficulties the most cost effective option for both 4mg and 8mg strength are the Setofilm® orodisperible films as the liquid and generically prescribed orodispersible tablets and melts are more expensive. These must be prescribed by brand Setofilm.

Please note these are still considerably more expensive then the normal release tablets.

MHRA advice: Ondansetron- small increased risk of oral clefts following use in the first 12 weeks of pregnancy (Jan 2020)

 
   
04.06  Expand sub section  Neurokinin receptor antagonist
04.06  Expand sub section  Other drugs for Ménière's disease
 ....
 Non Formulary Items
Dolasetron Mesilate  (Anzemet®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Granisetron transdermal patch  (Sancuso®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ondansetron  (Zofran®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary Do not prescribe this brand, prescribe generically where appropriate as indicated by formulary entry
 
Palonosetron  (Aloxi®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tropisetron  (Navoban®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary